ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 98 filers reported holding ENDOCYTE INC in Q2 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,768,000 | 0.0% | 194,500 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $1,768,000 | +40.7% | 194,500 | -33.7% | 0.00% | +100.0% |
| Q4 2017 | $1,257,000 | +330.5% | 293,580 | +42.0% | 0.00% | – |
| Q3 2017 | $292,000 | +61.3% | 206,780 | +71.3% | 0.00% | – |
| Q2 2017 | $181,000 | -63.4% | 120,724 | -37.3% | 0.00% | -100.0% |
| Q1 2017 | $495,000 | +286.7% | 192,561 | +284.4% | 0.00% | – |
| Q4 2016 | $128,000 | -78.1% | 50,100 | -73.5% | 0.00% | -100.0% |
| Q3 2016 | $584,000 | +196.4% | 189,000 | +198.1% | 0.00% | – |
| Q1 2016 | $197,000 | -3.9% | 63,400 | +23.9% | 0.00% | – |
| Q4 2015 | $205,000 | -38.4% | 51,161 | -29.6% | 0.00% | -100.0% |
| Q3 2015 | $333,000 | -83.4% | 72,699 | -81.2% | 0.00% | -80.0% |
| Q2 2015 | $2,004,000 | -15.5% | 386,112 | +1.8% | 0.01% | 0.0% |
| Q1 2015 | $2,373,000 | -29.8% | 379,100 | -29.5% | 0.01% | -37.5% |
| Q4 2014 | $3,380,000 | +397.8% | 537,405 | +381.1% | 0.01% | +300.0% |
| Q3 2014 | $679,000 | -51.0% | 111,700 | -46.9% | 0.00% | -33.3% |
| Q2 2014 | $1,385,000 | +47.7% | 210,200 | +198.6% | 0.00% | +50.0% |
| Q3 2013 | $938,000 | +169.5% | 70,400 | +165.7% | 0.00% | +100.0% |
| Q2 2013 | $348,000 | – | 26,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|